Last reviewed · How we verify
High dose ADP101
At a glance
| Generic name | High dose ADP101 |
|---|---|
| Also known as | 4500mg target dose ADP101 |
| Sponsor | Alladapt Immunotherapeutics, Inc. |
| Modality | Biologic |
| Phase | Phase 1 |
Approved indications
Common side effects
Key clinical trials
- ADP101 for Oral Immunotherapy in Food-Allergic Children and Adults (PHASE1, PHASE2)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |